The use of a standardized Chinese herbal formula in patients with advanced lung cancer: a feasibility study
ConclusionThis study provides preliminary evidence that short-term use of a carefully selected and prepared CH formula in patients with stage 4 NSCLC is acceptable and safe.
Source: Journal of Integrative Medicine - Category: Complementary Medicine Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Complementary Medicine | Hematology | Herbs | Lung Cancer | Non-Small Cell Lung Cancer | Study | Toxicology